In 2023, the hospital discharge rate for intervertebral disc disorder cases in Canada was not specified, but starting in 2024, we see a forecasted decline. From 2024 to 2028, the rate decreases from 27.1 to 25.1 discharges per 100,000 persons, hinting at a downward trend. This corresponds to an average annual decline or CAGR over these years. The year-on-year decline is consistent, with each year showing approximately a 1.85% decrease.
Future trends to watch for include advances in non-surgical treatments, preventive measures, and enhanced rehabilitation techniques, which may further reduce hospitalization rates. Monitoring demographic shifts and lifestyle changes will also be significant.
Our readers also like:
Forecast: Hospital Discharges for Systemic Connective Tissue Disorders in Canada
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in the UK
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
European Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases by Country
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2023
- ReportLinker Research
Global Hospital Discharges for Systemic Connective Tissue Disorders by Country
- Units (Hospital Discharges)
- 2023
- ReportLinker Research
Forecast: Hospital Discharges for Soft Tissue Disorders Cases in France
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Global Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases by Country
- Units (Hospital Discharges)
- 2023
- ReportLinker Research
Forecast: Hospital Discharges for Systemic Connective Tissue Disorders in Italy
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Soft Tissue Disorders Cases in Italy
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Systemic Connective Tissue Disorders Cases in Italy
- Days
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases in France
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Soft Tissue Disorders Cases in Germany
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Soft Tissue Disorders Cases in the UK
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Soft Tissue Disorders Cases in the UK
- Days
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases in Germany
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Italy
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases in Germany
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Intervertebral Disc Disorders Cases in the UK
- Days
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Italy
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Canada
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases in Italy
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research